Kohjin BioKohjin Bio Co., Ltd.177A東証グロース医薬品FY ending Mar 2026, consolidated, J-GAAP

What does Kohjin Bio do with its cash?

How cash from operations was spent on investment, dividends, buybacks and more.

Operating cash flow
¥698.5M
Capex
¥970.1M
of revenue 19.6%
Free cash flow
-¥271.6M
Returned to shareholders
¥122.5M
of net income: 49%
Dividend per share
¥10
Payout ratio (reported)
81.5%

Cash flow ratios

Cash conversion, investment and shareholder payments calculated from disclosed figures.

Net income¥251M
Operating cash flow¥698.5M
Cash conversion (operating CF ÷ operating income)
204.5%
Cash vs. profit gap
¥447.5M(純利益の 178.3%)
Shareholder payments — dividends
of net income 48.8%
CapEx intensity (capex ÷ revenue)
19.6%
Investing CF relative to operating CF
124.2%

Nonpositive profit and free cash flow are omitted as ratio denominators. Amounts use the period's reported currency.

Five-year trend

Operating cash flow¥698.5M
FY ending Mar 2023: ¥461.2M¥461.2MFY ending Mar 2024: ¥823.7M¥823.7MFY ending Mar 2025: ¥915.6M¥915.6MFY ending Mar 2026: ¥698.5M¥698.5MFY23FY24FY25FY26
Free cash flow-¥271.6M
FY ending Mar 2023: -¥99.5M-¥99.5MFY ending Mar 2024: ¥260.9M¥260.9MFY ending Mar 2025: ¥28.1M¥28.1MFY ending Mar 2026: -¥271.6M-¥271.6MFY23FY24FY25FY26
Net income¥251M
FY ending Mar 2023: ¥829.8M¥829.8MFY ending Mar 2024: ¥385M¥385MFY ending Mar 2025: ¥794.8M¥794.8MFY ending Mar 2026: ¥251M¥251MFY23FY24FY25FY26

How to read this

  • Operating cash flow is the cash the core business actually brought in, including changes in receivables and inventory.
  • Free cash flow = operating cash flow − capital expenditure: a gauge of cash available for other uses.
  • Large "borrowing" or "cash drawdown" flows mean the company spent more than it generated that year.

Sources

Show source documents (3)
  • EDINET (FSA Japan)

    有価証券報告書-第45期(2025/04/01-2026/03/31)

    ID S100YB5D2026-06-23Open
  • EDINET (FSA Japan)

    有価証券報告書-第44期(2024/04/01-2025/03/31)

    ID S100W2HI2025-06-24Open
  • EDINET (FSA Japan)

    有価証券報告書-第43期(2023/04/01-2024/03/31)

    ID S100TX402024-06-28Open

Extracted from XBRL: 48 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.